Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300075593Phase 4Not yet recruiting
Phase 4, randomised trial in None comparing Propofol group with Remimazolam group (2 arms). Primary endpoints: Recovery time, Tracheal catheter removal time and 1 more. Planned start Sep 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300075593.